LBA23 Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial

J. Taieb, O. Bouche, T. André, E. Barbier, P. Laurent-Puig, J. Bez, C. Toullec, C. Borg, V. Randrian, L. Evesque,

Annals of Oncology · 2022 · 10 citations · 0 references

Concepts